How Sex and Gender Impact Clinical Practice - 1st Edition - ISBN: 9780128165690

How Sex and Gender Impact Clinical Practice

1st Edition

An Evidence-Based Guide to Patient Care

0.0 star rating Write a review
Editors: Marjorie Jenkins Connie Newman
Paperback ISBN: 9780128165690
Imprint: Academic Press
Published Date: 1st June 2020
Page Count: 375
Sales tax will be calculated at check-out Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

How Sex and Gender Impact Clinical Practice: An Evidence-Based Guide to Patient Care enables primary care clinicians by providing a framework to understand differences and better care for patients in their practice. Each chapter covers a subspecialty in medicine and discusses the influence of sex hormones on disease, along with sex and gender-based differences in clinical presentation, physical examination, laboratory results, treatment regimens, comorbidities and prognosis. Illustrative case examples and practical practice points help each chapter come alive. A special chapter on communication differences between men and women assists clinicians in their conversations with patients.

This book fills an important need by applying years of research findings to sex and gender specific medical care and demonstrating that an individualized approach to patient care will lead to improved detection, treatment and prevention of disease.

Key Features

  • Explores the effects of sex and gender on disease presentation, treatment and prognosis, and how these differences influence clinical decision-making
  • Provides practical guidance that helps clinicians implement a more individualized approach to patient care
  • Contains information on diseases in each major specialty, as well as chapters on communication, pharmacology and public health challenges

Readership

Biomedical researchers in endocrinology, cardiology, neuroscience, and development biology; medical students, residents, and practicing primary care clinicians as well as PAs and NPs.

Table of Contents

Foreword
Maryanne Legato
Introduction
Connie Newman and Marjorie R. Jenkins

Section I: The Importance of Sex and Gender in Patient Care
1. Application of Sex and Gender Health: A Practical Framework
Marjorie R. Jenkins and Catherine A. Johnson
2. Clinician-Patient Communication: Gender Influences
Amy Koerber and Kaye Renshaw

Section II: Sex and Gender Evidence in Health and Disease
3. Addiction: Sex and Gender Evidence in Alcohol, Tobacco, and Opioids Substance Use Disorders
Mishka Terplan, Caitlin Martin and Anna Scialli
4. Autoimmune Diseases: Sex and Gender Evidence in Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Ankylosing Spondylitis
Kristen Demoruelle and Emily Bowers
5. Cancer Screening and Prevention: Sex and Gender Evidence in Lung, Breast, and Colorectal Cancer 
Rashmi Verma and Manojna Konda
6. Cardiovascular Disease: Sex and Gender Evidence in Acute Ischemic Syndrome and Heart Failure
Basmah Safdar
7. Gastrointestinal Diseases: Sex and Gender Evidence in Liver Lesions, Gastroesophageal Reflux, and Inflammatory Bowel Disease
Dina Halegoua-De Marzio and Sanaa Arastu
8. Mental Health: Sex and Gender Evidence in Schizophrenia, Depression, and Anxiety Disorders
Susan Kornstein and Bushra Shah
9. Metabolic Disorders: Sex and Gender Evidence in Dyslipidemia, Diabetes, and Obesity
Connie Newman, Katherine Saunders and Savitha Subramanian
10. Musculoskeletal Disorders: Sex and Gender Evidence in ACL Injuries, Osteoarthritis, and Osteoporosis
Kimberly Templeton
11. Neurological Diseases: Sex and Gender Evidence in Stroke, Migraine, and Alzheimer’s Dementia
Neelum Aggarwal
12. Pharmacology: Sex and Gender Evidence in Medication Safety and Efficacy
Rebecca Sleeper and Dr. Cox
13. Public Health in Your Practice: Sex and Gender Considerations in Access to Healthcare, Immunizations, and Intimate Partner Violence
Theresa Byrd and Rubini Pasupathy
14. Respiratory Diseases: Sex and Gender Evidence in Obstructive Sleep Apnea, COPD, and Asthma
Juliana Kling and Kathyrn Williams

Section III: Beyond Point of Care: Sex and Gender Influences in the Community of Practice
15. The Business of Medicine: Making the Case for a Sex and Gender Practice
Marjorie R. Jenkins
16. Knowledge Resources in Sex and Gender Health
Janice L. Werbinski

Details

No. of pages:
375
Language:
English
Copyright:
© Academic Press 2020
Published:
1st June 2020
Imprint:
Academic Press
Paperback ISBN:
9780128165690

About the Editor

Marjorie Jenkins

Dr. Jenkins is Director of Medical Initiatives and Scientific Engagement at the U.S. Food and Drug Administration Office of Women’s Health (OWH); Graduate Research Program Director, Master of Education for Health Professions at Johns Hopkins University, College of Education. She is also a Professor, Internal Medicine at Texas Tech University Health Sciences Center, Department of Obstetrics and Gynecology; Associate Dean for Women in Health, Director and Chief Scientific Officer; and Founding Director and Chief Scientific Officer for the Laura W. Bush Institute for Women’s Health and the J. Avery Rush Endowed Chair for Excellence in Women’s Health Research. Prior to her career in medicine, she received a degree in Chemical Engineering and was employed at Kodak Eastman Chemical Company as a control system engineer.

Affiliations and Expertise

Director of Medical Initiatives and Scientific Engagement, U.S. Food and Drug Administration Office of Women’s Health (OWH); Graduate Research Program Director, Master of Education for Health Professions, Johns Hopkins University, USA

Connie Newman

Adjunct Professor of Medicine at the New York University School of Medicine, is Board Certified in Internal Medicine, Endocrinology and Metabolism, and Obesity Medicine. She is a Fellow of the American College of Physicians, the American Heart Association and the American Medical Women’s Association (AMWA). She is the immediate Past President (2018-2019) of AMWA. Dr. Newman is recognized for her expertise in hypercholesterolemia, hypertriglyceridemia, statin safety, and randomized controlled clinical trials. She is the Chair of an Endocrine Society clinical practice guideline on the management of dyslipidemia in endocrine diseases, and was Chair of the writing group for the American Heart Association’s 2019 Scientific Statement on the safety of statins. Dr. Newman serves on the FDA Endocrine and Metabolic Disorders Advisory Committee.

Affiliations and Expertise

Adjunct Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, NYU School of Medicine, NY, USA

Ratings and Reviews